The latest news from RaySafe
New updated PTB certificate for RaySafe X2 (EN & DE)
RaySafe, the global leader of X-ray quality assurance solutions, has received a new updated PTB approval for RaySafe X2.
Unfors RaySafe, a Fluke Biomedical company, celebrates 1,000 real-time dosimetry system installations
Unfors RaySafe, the global leader of X-ray quality assurance solutions, celebrated its 1,000th installation of the RaySafe i2 dose management system at the European Congress of Radiology (ECR) in Vienna, Austria.
Unfors RaySafe unveils a new Survey sensor for the RaySafe X2
Unfors RaySafe, the global leader of X-ray quality assurance solutions, released a new radiation Survey sensor aimed at expanding the RaySafe X2 X-ray measurement system.
Fluke Biomedical launches online training center, bringing accessible training to the biomedical engineering community
Fluke Biomedical, the global leader in medical device quality assurance solutions, launched Advantage Training, an online center aimed at providing accessible training to the biomedical engineering community.
Fluke Biomedical releases its biggest test automation software update ever
Fluke Biomedical, the global leader in medical device quality assurance solutions, released Ansur 3.0 today, the largest update to its test automation software platform to date. Ansur 3.0 provides new login features, customization options and reporting choices to customers than ever before.
Understanding Medical Radiation
A new website established by Siemens Healthcare provides comprehensive, yet easy-to-understand, information about radiation in medical imaging.
EuroSafe Imaging Campaign
Unfors RaySafe supports the EuroSafe Imaging Campaign in its aim to promote quality and safety in medical imaging by joining forces with various stakeholders.
Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging
A White Paper published by the U.S. Food and Drug Administration (FDA) announces a cooperative Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging of FDA and other parties.